Optimization of Differential Diagnosis and Treatment of Children with Bronchial Obstruction Syndrome

The article presents the results of a comparative study of PulmoLOR® suspension in children aged 6-12 years with acute obstructive bronchitis diagnosis.

Conclusions: The expediency and effectiveness of combined PulmoLOR® (MoviHealth, Switzerland) medicine use for the faster reduction of main clinical manifestations of the disease (cough, sputum, rales) in children aged 6-12 years has been proved useful and effective in acute obstructive bronchitis treatment.